439 related articles for article (PubMed ID: 30245264)
21. Mesenchymal stem cell-mediated T cell suppression occurs through secreted galectins.
Sioud M; Mobergslien A; Boudabous A; Fløisand Y
Int J Oncol; 2011 Feb; 38(2):385-90. PubMed ID: 21165555
[TBL] [Abstract][Full Text] [Related]
22. Mesenchymal niche remodeling impairs hematopoiesis via stanniocalcin 1 in acute myeloid leukemia.
Waclawiczek A; Hamilton A; Rouault-Pierre K; Abarrategi A; Albornoz MG; Miraki-Moud F; Bah N; Gribben J; Fitzgibbon J; Taussig D; Bonnet D
J Clin Invest; 2020 Jun; 130(6):3038-3050. PubMed ID: 32364536
[TBL] [Abstract][Full Text] [Related]
23. Role of Galectins in Multiple Myeloma.
Storti P; Marchica V; Giuliani N
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29258207
[TBL] [Abstract][Full Text] [Related]
24. Hypoxia-CXCL6 axis affects arteriolar niche remodeling in acute myeloid leukemia.
Li L; Man J; Zhao L
Exp Biol Med (Maywood); 2021 Jan; 246(1):84-96. PubMed ID: 33167688
[TBL] [Abstract][Full Text] [Related]
25. Galectins as potential emerging key targets in different types of leukemia.
Zheng Y; Feng W; Wang YJ; Sun Y; Shi G; Yu Q
Eur J Pharmacol; 2019 Feb; 844():73-78. PubMed ID: 30452910
[TBL] [Abstract][Full Text] [Related]
26. Galectin-1 induces gene and protein expression related to maternal-conceptus immune tolerance in bovine endometrium†.
Chaney HL; Grose LF; LaBarbara JM; Sirk AW; Blancke AM; Sánchez JM; Passaro C; Lonergan P; Mathew DJ
Biol Reprod; 2022 Mar; 106(3):487-502. PubMed ID: 34792096
[TBL] [Abstract][Full Text] [Related]
27. Overcoming Microenvironment-Mediated Chemoprotection through Stromal Galectin-3 Inhibition in Acute Lymphoblastic Leukemia.
Tarighat SS; Fei F; Joo EJ; Abdel-Azim H; Yang L; Geng H; Bum-Erdene K; Grice ID; von Itzstein M; Blanchard H; Heisterkamp N
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830047
[TBL] [Abstract][Full Text] [Related]
28. Molecular alterations in bone marrow mesenchymal stromal cells derived from acute myeloid leukemia patients.
von der Heide EK; Neumann M; Vosberg S; James AR; Schroeder MP; Ortiz-Tanchez J; Isaakidis K; Schlee C; Luther M; Jöhrens K; Anagnostopoulos I; Mochmann LH; Nowak D; Hofmann WK; Greif PA; Baldus CD
Leukemia; 2017 May; 31(5):1069-1078. PubMed ID: 27833093
[TBL] [Abstract][Full Text] [Related]
29. Stanniocalcin 1 is overexpressed in multipotent mesenchymal stromal cells from acute myeloid leukemia patients.
Schelker RC; Kratzer A; Müller G; Brochhausen C; Hart C; Stempfl T; Heudobler D; Moehle C; Herr W; Iberl S; Grassinger J
Hematology; 2021 Dec; 26(1):565-576. PubMed ID: 34384344
[No Abstract] [Full Text] [Related]
30. MIF-Induced Stromal PKCβ/IL8 Is Essential in Human Acute Myeloid Leukemia.
Abdul-Aziz AM; Shafat MS; Mehta TK; Di Palma F; Lawes MJ; Rushworth SA; Bowles KM
Cancer Res; 2017 Jan; 77(2):303-311. PubMed ID: 27872094
[TBL] [Abstract][Full Text] [Related]
31. Stem cell niche as a prognostic factor in leukemia.
Lee GY; Kim JA; Oh IH
BMB Rep; 2015 Aug; 48(8):427-8. PubMed ID: 26198094
[TBL] [Abstract][Full Text] [Related]
32. Acute myeloid leukemia induces protumoral p16INK4a-driven senescence in the bone marrow microenvironment.
Abdul-Aziz AM; Sun Y; Hellmich C; Marlein CR; Mistry J; Forde E; Piddock RE; Shafat MS; Morfakis A; Mehta T; Di Palma F; Macaulay I; Ingham CJ; Haestier A; Collins A; Campisi J; Bowles KM; Rushworth SA
Blood; 2019 Jan; 133(5):446-456. PubMed ID: 30401703
[TBL] [Abstract][Full Text] [Related]
33. Gene polymorphisms of LGALS2, LGALS3 and LGALS9 in patients with rheumatoid arthritis.
Xu WD; Wu Q; He YW; Huang AF; Lan YY; Fu L; Zhou J; Liu XY
Cell Immunol; 2021 Oct; 368():104419. PubMed ID: 34371260
[TBL] [Abstract][Full Text] [Related]
34. Alterations in multipotent mesenchymal stromal cells from the bone marrow of acute myeloid leukemia patients at diagnosis and during treatment.
Shipounova IN; Petinati NA; Bigildeev AE; Sorokina TV; Kuzmina LA; Parovichnikova EN; Savchenko VG
Leuk Lymphoma; 2019 Aug; 60(8):2042-2049. PubMed ID: 30668205
[TBL] [Abstract][Full Text] [Related]
35. Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?
Pleyer L; Valent P; Greil R
Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27355944
[TBL] [Abstract][Full Text] [Related]
36. CXCL8 derived from mesenchymal stromal cells supports survival and proliferation of acute myeloid leukemia cells through the PI3K/AKT pathway.
Cheng J; Li Y; Liu S; Jiang Y; Ma J; Wan L; Li Q; Pang T
FASEB J; 2019 Apr; 33(4):4755-4764. PubMed ID: 30592634
[TBL] [Abstract][Full Text] [Related]
37. Transforming the Niche: The Emerging Role of Extracellular Vesicles in Acute Myeloid Leukaemia Progression.
Mendes M; Monteiro AC; Neto E; Barrias CC; Sobrinho-Simões MA; Duarte D; Caires HR
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674015
[TBL] [Abstract][Full Text] [Related]
38. New insights into mesenchymal stromal cell-mediated T-cell suppression through galectins.
Sioud M
Scand J Immunol; 2011 Feb; 73(2):79-84. PubMed ID: 21198747
[TBL] [Abstract][Full Text] [Related]
39. Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells.
Chapellier M; Peña-Martínez P; Ramakrishnan R; Eriksson M; Talkhoncheh MS; Orsmark-Pietras C; Lilljebjörn H; Högberg C; Hagström-Andersson A; Fioretos T; Larsson J; Järås M
Haematologica; 2019 Oct; 104(10):2006-2016. PubMed ID: 30819903
[TBL] [Abstract][Full Text] [Related]
40. Roles of the bone marrow niche in hematopoiesis, leukemogenesis, and chemotherapy resistance in acute myeloid leukemia.
Wang A; Zhong H
Hematology; 2018 Dec; 23(10):729-739. PubMed ID: 29902132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
